Glycogen storage disease type 7, also known as phospholirosine gene mutation, is a rare hereditary disease that belongs to the group of glycogenoses. The main pathogenesis of the disease is a deficiency of the phospholirosine enzyme, which leads to the accumulation of glycogen in the muscles and metabolic disorders. The main clinical manifestations are associated with myopathy, which is identified mainly in children and adolescents. Symptoms include muscle weakness, fatigue, and cramps, which ultimately limit the physical activity and quality of life of patients. Another important aspect is the possibility of serious complications, including cardiovascular disorders.
History of the disease and interesting historical facts
Glycogen storage disease was first described in the mid-20th century, when scientists began to study hereditary metabolic disorders. In 1958, advances in genetics made it possible to establish an association between glycogen metabolism disorders and the pathology of phospholirosaemia. An interesting fact is that with each new discovery about glycogenoses, many mutations that affect enzyme activity became known. This contributed not only to understanding the mechanisms of the disease, but also to the development of diagnostic and treatment methods. One of the important discoveries concerned the identification of mutations in genes, which significantly updated genetic counseling for patients and their families.
Epidemiology
The epidemiology of glycogen storage disease type 7 indicates that the disorder is rare, with an estimated incidence of approximately 1 in 100,000 live births. Despite this, the incidence varies depending on population structure and genetic factors in different geographic regions. Research data suggests that as time passes, understanding and diagnosis of the condition is becoming more accessible, resulting in an increase in the number of reported cases.
Genetic predisposition to this disease
Glycogen storage disease type 7 is caused by mutations in the gene encoding phospholirosine (PYGM), located on chromosome 11. These mutations can be varied, including point mutations, deletions, and insertions. The disorder is known to be inherited in an autosomal recessive manner, meaning that both parents must pass on the mutated gene to their offspring for the disorder to develop. Genetic analysis and molecular testing are important for diagnosis and to determine the likelihood of risk in families.
Risk factors for the development of this disease
Risk factors for glycogen storage disease type 7 are mostly hereditary. The main ones include:
- Family history of glycogen storage disease.
- Geographic and ethnic groups with high incidence of the disease.
- Classic genetic mutations that contribute to the development of the disease.
The need for genetic counseling is important for parents who want to know about possible risks for future children.
Diagnosis of this disease
Diagnosis of glycogen storage disease type 7 is based on the following aspects:
- Main symptoms: muscle weakness, fainting after physical exertion, seizures, and developmental delays.
- Laboratory tests: Blood biochemistry, determination of enzyme levels and accumulation of glycogen in muscles.
- Radiological examinations: Magnetic resonance imaging (MRI) to assess the condition of muscle tissue.
- Other types of disease diagnostics: muscle biopsy for morphological analysis.
- Differential diagnosis: Other myopathies and metabolic disorders must be excluded.
Treatment
Treatment of glycogen storage disease type 7 consists of a comprehensive approach:
- General treatment: Physiotherapy and specific exercise regimens to improve muscle function.
- Pharmacological treatment: drugs aimed at reducing glycogen accumulation and improving metabolism.
- Surgical treatment: In extreme cases, intervention may be indicated to correct complications.
- Other types of treatment: supportive therapy, use of carbohydrate-restricted diets.
List of medications used to treat this disease
Drugs used to treat glycogen storage disease type 7 include:
- Creatine
- Coenzyme Q10
- Various vitamin complexes
- Beta-carotene
It is important that all prescriptions are carried out only under the supervision of a physician.
Disease monitoring
Monitoring of patients with glycogen storage disease type 7 includes:
- Control stages: regular check-ups with a specialist and biochemical tests.
- Forecast: With timely diagnosis and treatment, normalization of the condition and quality of life is possible, although muscle function may deteriorate over time.
- Complications: possible cardiovascular diseases, breathing problems and physical activity.
Age-related features of the disease
In children, the disease may manifest itself in the early stages with severe muscle weakness and delayed physical development. In adulthood, the clinical picture may be less pronounced, but many patients face limitations in physical activity. In older people, the disease progression process may become more acute, leading to significant loss of mobility and functional capabilities.
Questions and Answers
- What is glycogen storage disease type 7? It is a hereditary disease associated with a deficiency of the enzyme phospholisarcoidosis, leading to the accumulation of glycogen in the muscles.
- How is this disease diagnosed? Diagnosis includes laboratory tests, muscle biopsy and genetic testing.
- What are the treatment methods? Treatment can be general (physiotherapy), pharmacological and, in some cases, surgical.
- What is the prognosis for patients with this disease? The prognosis depends on the stage and timeliness of treatment, but relief of the condition and improvement in quality of life are possible.
- Who is at risk for the disease? The main risk factor is a family history of the disease.
Advice from Dr. Oleg Korzhikov
Seeking medical attention at the first signs, such as muscle weakness or fatigue, can significantly improve your quality of life. I recommend regular exercise that is appropriate for your condition and taking your individual circumstances into account when creating a training program. It is also important to monitor your general health and have regular check-ups to monitor for possible complications. Diet plays a significant role: avoiding foods high in carbohydrates can help improve the condition.
